SCHEMBL29292374

SCHEMBL29292374

CCC(=O)Nc1ccc2c(c1)[C@@]1(C)CCCC(C(=O)N(C)C(=O)C3CCCC4(C)c5cc(N)ccc5CCC34)C1CC2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 2/20 0.37
▸ BACE1 P56817 3/20 0.35
▸ NR1H2 P55055 3/20 0.35
▸ NR1H3 Q13133 3/20 0.35
▸ MCHR1 Q99705 2/20 0.35
▸ HPGD P15428 2/20 0.33
▸ POLB P06746 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ POLA1 P09884 2/20 0.32
▸ CYP3A4 P08684 2/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29295655 1.00 RAB9A (0.37) RAB9ABACE1NR1H2NR1H3MCHR1
SCHEMBL29295648 0.93 NR1H2 (0.35) RAB9ABACE1NR1H2NR1H3MCHR1
SCHEMBL21569827 0.92 NR1H2 (0.34) RAB9ABACE1NR1H2NR1H3MCHR1
SCHEMBL29296723 0.91 NR1H2 (0.43) NR1H2NR1H3POLA1
SCHEMBL29292400 0.90 NR1H2 (0.46) RAB9ANR1H2NR1H3POLA1
SCHEMBL29292376 0.88 NR1H2 (0.38) NR1H2NR1H3POLA1CYP3A4CYP2C19
SCHEMBL29292359 0.84 NR1H2 (0.43) NR1H2NR1H3POLA1
SCHEMBL29297676 0.83 NR1H2 (0.38) NR1H2NR1H3POLA1
SCHEMBL29292394 0.82 NR1H2 (0.36) RAB9ABACE1NR1H2NR1H3MCHR1
SCHEMBL21569998 0.79 NR1H2 (0.45) NR1H2NR1H3POLA1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3883926-B1 BIS-OCTAHYDROPHENANTHRENE CARBOXAMIDE DERIVATIVES AND PROTEIN CONJUGATES THEREOF FOR USE AS LXR AGONISTS REGENERON PHARMA (US) 2024-07-10 — — EP disclosed
Send feedback